Association between <i>EGFR</i> mutation types and incidence of brain metastases in postoperative patients with stage I–III NSCLC
<i>EGFR</i> mutations are predictive factors for the cumulative incidence of brain metastasis. <i>EGFR</i>-mutant non-small-cell lung cancer patients may need more frequent brain magnetic resonance imaging to detect earlier occurrence of brain metastases, allowing for timely and effective treatment to improve patient prognosis.
Authors
- Chunhui Wu (ORCID: https://orcid.org/0000-0002-6108-7002)
- Chengzhi Zhou (ORCID: https://orcid.org/0000-0003-0029-6879)
- Jianqi Zheng (ORCID: https://orcid.org/0000-0002-7545-6323)
- Jiexia Zhang (ORCID: https://orcid.org/0000-0002-2254-862X)
- Huaming Lin
- Limian Wu
- Zhiling Xie
- Yuhao Zhou (ORCID: https://orcid.org/0000-0002-4567-387X)
- Zhiqiang Luo
- Hui Pan (ORCID: https://orcid.org/0000-0001-6873-5749)
- Lixuan Chen (ORCID: https://orcid.org/0000-0002-0333-7990)
- Jian Huang (ORCID: https://orcid.org/0000-0003-3340-5007)
- Jiaqing Zhang (ORCID: https://orcid.org/0000-0002-3385-0277)
Institutions
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Zhujiang Hospital (CN)
- State Key Laboratory of Respiratory Disease (CN)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Tumori Journal
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1177/03008916251343724
- Citations
- 3
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- State Key Laboratory of Respiratory Disease
- Guangzhou Municipal Science and Technology Project